1. Bauernfeind, A., Petermüller, C. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur. J. Clin. Microbiol. 2, 2 (1983) 111–115.
2. Seibert, G., Limbert, M., Klesel, N. Comparison of the antibacterialin vitro andin vivo activity of ofloxacin (HOE 280, DL 8280) and nalidixic acid analogues. Eur. J. Clin. Microbiol. 2 (1983) 548–553.
3. Kumada, T., Neu, H. C. DL-8280, a quinolone antibacterial agent with broad-spectrum activity. Proceedings from the 13th International Congress of Chemotherapy, Vienna 1983. Poster Presentations, Tom 5, SP 4.6/5-1, 125/1-5; Eds.Spitzy, K. H., Karrer, K. et al., Verlag H. Egermann, Vienna 1983.
4. Sato, K., Inoue, M., Mitsuhashi, S. In vitro andin vivo antibacterial activity of a new pyridonecarboxylic acid, DL-8280. Proceedings from the 13th International Congress of Chemotherapy, Vienna 1983. Poster Presentations, Tom 5, SP 4.6/5-2, 125/6-9; Eds.Spitzy, K. H., Karrer, K. et al., Verlag H. Egermann, Vienna 1983.
5. Masuda, G., Negishi, M., Young, C., Mizuoka, K. Timed bacteriostatic and bactericidal activities of DL-8280 againstE. coli, Klebsiella sp. andS. aureus. Proceedings from the 13th International Congress of Chemotherapy, Vienna 1983. Poster Presentations, Tom 5, SP 4.6/5-3, 125/10-12; Eds.Spitzy, K. H., Karrer, K. et al., Verlag H. Egermann, Vienna 1983.